New device aims to zap small lung tumors before surgery
NCT ID NCT07122258
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study is testing the safety of a new device called CAROL for treating small lung tumors (≤2 cm) in people with non-small cell lung cancer. Seven participants will receive a single treatment with the device, followed by surgical removal of the tumor. The main goal is to see if the device is safe and to check for any side effects within the first month.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CAROL device (a conformable electrode for tumor ablation)
What this could lead to
If successful, this could lead to a less invasive treatment option for small lung tumors, potentially reducing the need for more extensive surgery.
What could go wrong
This is a very early, small safety study with only 7 participants. The device may not work as intended, and risks include side effects from the procedure. It is not yet proven to be effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Melbourne Hospital
RECRUITINGMelbourne, Victoria, 3050, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••